Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap25.88B
Enterprise Value31.63B
P/E Ratio12.46
PEG Ratio-1.44
Price/Sales Ratio0.41
Price/Book Ratio0.71
Enterprise/Revenue0.49
Enterprise/EBITDA9.34

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue77.66B
Revenue/Share54.91
Gross Profit12.52B
EBITDA3.95B
Net Income2.98B
Diluted EPS1.83

Balance Sheet

Total Cash25.66B
Total Cash/Share9.37
Total Debt19.54B
Total Debt/Equity0.5
Current Ratio0.2
Book Value Per Share29.24

Price History

52-Week Change-28.26
52-Week High20.4
52-Week Low13.27
Moving Average 50 Days15.03
Moving Average 200 Days16.92

Statistics

Average Volume1.05M
Shares Outstanding2.48B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.75
Trailing Annual Dividend Yield3.81
Payout Ratio0.83
Last Split FactorN/A
Last Split DateN/A
AD